Takeda is a leading, values-based, R&D-driven, biopharmaceutical company headquartered in Japan. Takeda's mission is to develop and produce life-transforming medicines for the treatment of rare and complex diseases. The focus is on the supply of patients for whom no or only a few treatment options are available. At Takeda in Austria, every step of the process for innovative medicines takes place: from research and development, plasma sourcing and manufacturing to patient supply.
R&D:Biologics and plasma-derived products for the fields of oncology, rare metabolic diseases, gastroenterology and immunology, among others.
Production:Biologics and plasma-derived products for the fields of oncology, rare metabolic diseases, gastroenterology and immunology, among others. Patients in more than 100 countries are supplied from Austria.
Sales/Distribution:The Austrian product portfolio helps patients in the fields of oncology, rare metabolic diseases, gastroenterology and immunology, among others.